AMRI
With locations in North America, Europe, and Asia, AMRI’s team combines scientific expertise and market-leading technology to provide a complete suite of solutions in Drug Discovery, Development, Analytical Services, API Manufacturing, and Drug Product.
AMRI, a global contract research and manufacturing organization, partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life. With locations in North America, Europe, and Asia, AMRI’s team combines scientific expertise and market-leading technology to provide a complete suite of solutions in Drug Discovery, Development, Analytical Services, API Manufacturing, and Drug Product. Discover our expert solutions at amriglobal.com
AMRI
26 Corporate Circle, Albany, NY 12203, USA
tel. 518.512.2000
Customerservice@amriglobal.com
AAPS Booth Number: 1809
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
